These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

160 related articles for article (PubMed ID: 31364100)

  • 1. The Role of Ciprofloxacin Resistance and Extended-spectrum beta-lactamase (ESBL) Positivity in Infective Complications Following Prostate Biopsy.
    Korkmaz N; Gurbuz Y; Sandikci F; Kul G; Tutuncu EE; Sencan I
    Urol J; 2020 Mar; 17(2):192-197. PubMed ID: 31364100
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Trial Comparing a Combined Regimen of Amikacin and Ciprofloxacin to Ciprofloxacin Alone as Transrectal Prostate Biopsy Prophylaxis in the Era of High Fluoroquinolone-Resistant Rectal Flora.
    Son KC; Chung HS; Jung SI; Kim MS; Hwang EC; Kim JW; Kwon DD
    J Korean Med Sci; 2018 Apr; 33(15):e113. PubMed ID: 29629517
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Ciprofloxacin resistance in the faecal carriage of patients undergoing transrectal ultrasound guided prostate biopsy.
    Taylor S; Margolick J; Abughosh Z; Goldenberg SL; Lange D; Bowie WR; Bell R; Roscoe D; Machan L; Black P
    BJU Int; 2013 May; 111(6):946-53. PubMed ID: 23464844
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Extended-spectrum β-lactamase in the rectal flora of patients undergoing transrectal prostate biopsy: a study of the prevalence in a major metropolitan hospital.
    Sewell J; Chow K; De Sousa A; Sapre N; Norris B; Namdarian B; Sinickas V; Huang JG; Anderson P
    BJU Int; 2019 May; 123 Suppl 5():43-46. PubMed ID: 31012990
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Prevalence and characteristics of fecal antimicrobial-resistant Escherichia coli in a cohort of Japanese men undergoing prostate biopsy.
    Kamei J; Yagihara Y; Kume H; Horiuchi T; Sato T; Nakagawa T; Fujimura T; Fukuhara H; Moriya K; Homma Y
    Int J Urol; 2017 Apr; 24(4):295-300. PubMed ID: 28222483
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Increasing prevalence of ciprofloxacin resistance in extended-spectrum-β-lactamase-producing Escherichia coli urinary isolates.
    Bonkat G; Müller G; Braissant O; Frei R; Tschudin-Suter S; Rieken M; Wyler S; Gasser TC; Bachmann A; Widmer AF
    World J Urol; 2013 Dec; 31(6):1427-32. PubMed ID: 23358791
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Effect of Augmented Antimicrobial Prophylaxis and Rectal Swab Culture-guided Targeted Prophylaxis on the Risk of Sepsis Following Transrectal Prostate Biopsy.
    Hadjipavlou M; Eragat M; Kenny C; Pantelidou M; Mulhem W; Wood C; Dall'Antonia M; Hammadeh MY
    Eur Urol Focus; 2020 Jan; 6(1):95-101. PubMed ID: 31928632
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Prevalence of fluoroquinolone-resistant rectal flora in patients undergoing transrectal ultrasound-guided prostate needle biopsy: A prospective multicenter study.
    Chung HS; Hwang EC; Yu HS; Jung SI; Lee SJ; Lim DH; Cho WJ; Choe HS; Lee SJ; Park SW
    Int J Urol; 2018 Mar; 25(3):278-283. PubMed ID: 29241300
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Rectal E. coli above ciprofloxacin ECOFF associate with infectious complications following prostate biopsy.
    Kalalahti I; Huotari K; Lahdensuo K; Tarkka E; Santti H; Rannikko A; Pätäri-Sampo A
    Eur J Clin Microbiol Infect Dis; 2018 Jun; 37(6):1055-1060. PubMed ID: 29500572
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Antibiotic susceptibility of intestinal Escherichia coli in men undergoing transrectal prostate biopsies: a prospective, registered, multicentre study.
    Knaapila J; Kallio H; Hakanen AJ; Syvänen K; Ettala O; Kähkönen E; Lamminen T; Seppänen M; Jambor I; Rannikko A; Riikonen J; Munukka E; Eerola E; Gunell M; Boström PJ
    BJU Int; 2018 Aug; 122(2):203-210. PubMed ID: 29533507
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Evaluation of targeted antimicrobial prophylaxis for transrectal ultrasound guided prostate biopsy: a prospective cohort trial.
    Zembower TR; Maxwell KM; Nadler RB; Cashy J; Scheetz MH; Qi C; Schaeffer AJ
    BMC Infect Dis; 2017 Jun; 17(1):401. PubMed ID: 28592230
    [TBL] [Abstract][Full Text] [Related]  

  • 12. "Targeted" prophylaxis: Impact of rectal swab culture-directed prophylaxis on infectious complications after transrectal ultrasound-guided prostate biopsy.
    Singh P; Kumar A; Yadav S; Prakash L; Nayak B; Kumar R; Kapil A; Dogra PN
    Investig Clin Urol; 2017 Sep; 58(5):365-370. PubMed ID: 28868509
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Fluoroquinolone-resistant E. coli in intestinal flora of patients undergoing transrectal ultrasound-guided prostate biopsy--should we reassess our practices for antibiotic prophylaxis?
    Steensels D; Slabbaert K; De Wever L; Vermeersch P; Van Poppel H; Verhaegen J
    Clin Microbiol Infect; 2012 Jun; 18(6):575-81. PubMed ID: 21958149
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Infective complications in patients after transrectal ultrasound-guided prostate biopsy and the role of ciprofloxacin resistant
    Hamarat MB; Tarhan F; Horuz R; Öcal GA; Demirkol MK; Kafkaslı A; Yazıcı Ö
    Turk J Urol; 2017 Jun; 43(2):210-215. PubMed ID: 28717548
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Comparison of Single and Prolonged Fluoroquinolone Prophylaxis and Risk Factors for Infectious Complications After Transrectal Prostate Biopsy.
    Kalkanlı A; Gezmiş CT; Özkan A; Çilesiz NC; Yanaral F; Aydın M; Tandoğdu Z
    Balkan Med J; 2018 Sep; 35(5):373-377. PubMed ID: 29866640
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Prevalence of antibiotic resistance in fecal flora of patients undergoing transrectal ultrasound-guided prostate biopsy in Thailand.
    Siriboon S; Tiengrim S; Taweemongkongsup T; Thamlikitkul V; Chayakulkeeree M
    Urol Int; 2012; 88(2):187-93. PubMed ID: 22269856
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Antimicrobial susceptibilities of extended-spectrum beta-lactamase-producing Escherichia coli and Klebsiella pneumoniae in health care-associated urinary tract infection: focus on susceptibility to fosfomycin.
    Cho YH; Jung SI; Chung HS; Yu HS; Hwang EC; Kim SO; Kang TW; Kwon DD; Park K
    Int Urol Nephrol; 2015 Jul; 47(7):1059-66. PubMed ID: 26026972
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Impact of selective media for detecting fluoroquinolone-insusceptible/extended-spectrum beta-lactamase-producing Escherichia coli before transrectal prostate biopsy.
    Sadahira T; Wada K; Araki M; Ishii A; Watanabe T; Nasu Y; Tsugawa M; Takenaka T; Nasu Y; Kumon H
    Int J Urol; 2017 Dec; 24(12):842-847. PubMed ID: 28929546
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Chemoprophylaxis during transrectal prostate needle biopsy: critical analysis through randomized clinical trial.
    Elshal AM; Atwa AM; El-Nahas AR; El-Ghar MA; Gaber A; Elsawy E; Hashem A; Farag Y; Farg H; Elsorougy A; Fouda M; Nabeeh H; Mosbah A
    World J Urol; 2018 Nov; 36(11):1845-1852. PubMed ID: 29736609
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Antimicrobial susceptibilities of urinary extended-spectrum beta-lactamase-producing Escherichia coli and Klebsiella pneumoniae to fosfomycin and nitrofurantoin in a teaching hospital in Taiwan.
    Liu HY; Lin HC; Lin YC; Yu SH; Wu WH; Lee YJ
    J Microbiol Immunol Infect; 2011 Oct; 44(5):364-8. PubMed ID: 21524974
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.